Decoy Therapeutics has partnered with hVIVO to support the development and clinical trial preparation of its Designable Multi-Antiviral (D-MAV) candidates, which aim to treat multiple respiratory viruses with a single adaptable drug. This collaboration will help Decoy advance its lead antiviral candidates through Phase 1 and Phase 2a human proof-of-concept studies, leveraging hVIVO's expertise in clinical development and human challenge trials. The partnership aims to accelerate Decoy's innovative antiviral platform, which uses AI-driven design to create drugs that can adapt quickly to evolving viruses, potentially transforming antiviral treatment and pandemic preparedness. Decoy plans to pursue regulatory approvals in Europe, the UK, and the US as it moves toward clinical testing.
NVIDIA announced that leading Japanese companies in robotics and manufacturing are adopting its Cosmos, Isaac, Metropolis, and Jetson platforms to accelerate AI-powered intelligent machines across industries. The new Cosmos 3 Edge model enables real-...
Oil prices are rising sharply due to renewed US naval blockades on Iranian shipping and increased tensions in the Strait of Hormuz, a critical oil transit route. Brent crude is holding above $85 and WTI above $80, with forecasts suggesting WTI could ...
The US government announced it will impose a new 25% tariff on Brazilian ethanol starting next Wednesday, accusing Brazil of unfair trade practices. This tariff excludes major Brazilian exports like oil, beef, coffee, and aircraft parts. The move fol...
Alibaba and Baidu shares rose after Apple received approval from China's Cyberspace Administration to include Apple Intelligence, integrating Alibaba's Qwen AI model and Baidu's AI features into Apple devices in China. This partnership allows users t...
Ondo Finance has introduced the first tokenized stock representations backed by DTCC tokenized entitlements, joining major financial firms in a significant tokenization initiative. This move highlights Ondo's unique position in building infrastructur...
